Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
Resalis Therapeutics's investors include Sanofi, Claris Ventures, Sunstone Life Science Ventures, Italian Angels for Growth, Club degli Investitori.
Resalis Therapeutics is headquartered in Torino, Italy.
Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
Resalis Therapeutics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Resalis Therapeutics — Funding & Investors." VCBacked, October 28, 2024, https://www.vcbacked.co/company/resalis-therapeutics. Accessed November 12, 2026.
VCBacked. (2024). Resalis Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/resalis-therapeutics
{{cite web |title=Resalis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/resalis-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Resalis Therapeutics? Request a listing update